Feb 27, 2024 06:00AM
Dec 13, 2023 04:00PM
Dec 13, 2023 04:00PM
Nov 7, 2023 06:00AM
Sep 14, 2021 07:21AM
Feb 24, 2020 06:19AM
Feb 21, 2020 04:38PM Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
Feb 21, 2020 04:38PM
Feb 14, 2020 05:40AM
Jan 31, 2020 07:05AM
Jan 31, 2020 07:02AM
Jan 31, 2020 07:02AM
Jan 31, 2020 07:02AM
Jan 31, 2020 07:01AM Esperion Announces Positive CHMP Opinion for the Marketing Authorisation Application for Bempedoic Acid for the Treatment of Hypercholesterolemia and Mixed Dyslipidemia
Jan 31, 2020 07:01AM
Jan 31, 2020 07:01AM
Nov 6, 2019 07:30AM
Nov 6, 2019 07:30AM
Sep 5, 2019 07:33AM
Sep 5, 2019 07:30AM
Sep 5, 2019 07:30AM Esperion Completes Patient Enrollment in the Global CLEAR Cardiovascular Outcomes Trial for Bempedoic Acid
Aug 8, 2019 07:30AM
Aug 8, 2019 07:30AM
May 29, 2019 09:28AM
May 8, 2019 07:00AM
May 8, 2019 07:00AM
May 6, 2019 06:25AM
May 5, 2019 05:00PM Esperion Announces U.S. FDA Acceptance of New Drug Applications (NDAs) for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet for Filing and Regulatory Review
May 5, 2019 05:00PM
Sep 30, 2015 09:32AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All